Scientific Reports · 2015 · 34 citations · 28 references
MedicineOncologyRadiation OncologyClinical Radiation OncologyMolecular OncologyRadiobiologyBiological Effects Of RadiationExternal Beam RadiotherapyRadiation BiologyRadiation SensitivityRadiation TherapyRelative Biological EffectivenessCancer Cell RadiosensitivityCarbon Ion TherapyIntrinsic RadiosensitivityNon-homologous End Joining DefectsNon-homologous End Joining RegulationNon-small Cell Lung Cancer TherapyTherapeutic RadiosensitizationTumor Radiosensitivity
Carbon-ion radiotherapy (CIRT) holds promise to treat inoperable locally-advanced non-small cell lung carcinoma (NSCLC), a disease poorly controlled by standard chemoradiotherapy using X-rays. Since CIRT is an extremely limited medical resource, selection of NSCLC patients likely to benefit from it is important; however, biological predictors of response to CIRT are ill-defined. The present study investigated the association between the mutational status of EGFR and KRAS, driver genes frequently mutated in NSCLC, and the relative biological effectiveness (RBE) of carbon-ion beams over X-rays. The assessment of 15 NSCLC lines of different EGFR/KRAS mutational status and that of isogenic NSCLC lines expressing wild-type or mutant EGFR revealed that EGFR-mutant NSCLC cells, but not KRAS-mutant cells, show low RBE. This was attributable to (i) the high X-ray sensitivity of EGFR-mutant cells, since EGFR mutation is associated with a defect in non-homologous end joining, a major pathway for DNA double-strand break (DSB) repair, and (ii) the strong cell-killing effect of carbon-ion beams due to poor repair of carbon-ion beam-induced DSBs regardless of EGFR mutation status. These data highlight the potential of EGFR mutation status as a predictor of response to CIRT, i.e., CIRT may show a high therapeutic index in EGFR mutation-negative NSCLC.
28
Comprehensive genomic characterization of squamous cell lung cancers
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Marcin Imieliński, Alice H. Berger, Peter S. Hammerman et al. · Cell · 2012 · 1.8K citations · Full text
Kiyoyuki Furuse, Masahiro Fukuoka, Masaaki Kawahara et al. · Journal of Clinical Oncology · 1999 · 1.5K citations
Walter J. Curran, Rebecca Paulus, Corey J. Langer et al. · JNCI Journal of the National Cancer Institute · 2011 · 1.2K citations · Full text